Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma
- PMID: 23527308
- PMCID: PMC3603933
- DOI: 10.1371/journal.pone.0060156
Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma
Abstract
Primary open angle glaucoma (POAG) is a leading cause of blindness worldwide. The molecular signaling involved in the pathogenesis of POAG remains unknown. Here, we report that mice lacking the α1 subunit of the nitric oxide receptor soluble guanylate cyclase represent a novel and translatable animal model of POAG, characterized by thinning of the retinal nerve fiber layer and loss of optic nerve axons in the context of an open iridocorneal angle. The optic neuropathy associated with soluble guanylate cyclase α1-deficiency was accompanied by modestly increased intraocular pressure and retinal vascular dysfunction. Moreover, data from a candidate gene association study suggests that a variant in the locus containing the genes encoding for the α1 and β1 subunits of soluble guanylate cyclase is associated with POAG in patients presenting with initial paracentral vision loss, a disease subtype thought to be associated with vascular dysregulation. These findings provide new insights into the pathogenesis and genetics of POAG and suggest new therapeutic strategies for POAG.
Conflict of interest statement
Figures






References
-
- Weinreb RN, Khaw PT (2004) Primary open-angle glaucoma. Lancet 363: 1711–1720. - PubMed
-
- Quigley HA (2011) Glaucoma. Lancet 377: 1367–1377. - PubMed
-
- Flammer J, Orgul S, Costa VP, Orzalesi N, Krieglstein GK, et al. (2002) The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 21: 359–393. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 HG004728/HG/NHGRI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- R01 EY022746-01/EY/NEI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- S10 RR022586/RR/NCRR NIH HHS/United States
- EY09611/EY/NEI NIH HHS/United States
- R01 EY015473/EY/NEI NIH HHS/United States
- R01 EY009611/EY/NEI NIH HHS/United States
- UL1 RR025758/RR/NCRR NIH HHS/United States
- R01 EY022746/EY/NEI NIH HHS/United States
- R01 EY022634/EY/NEI NIH HHS/United States
- CA87969/CA/NCI NIH HHS/United States
- R21 EY018712/EY/NEI NIH HHS/United States
- R21 EY020987/EY/NEI NIH HHS/United States
- CA49449/CA/NCI NIH HHS/United States
- R21 EY022766/EY/NEI NIH HHS/United States
- 5U01HG004728/HG/NHGRI NIH HHS/United States
- R01 CA049449/CA/NCI NIH HHS/United States
- P30 EY014104/EY/NEI NIH HHS/United States
- R01 EY015872/EY/NEI NIH HHS/United States
- UL1 RR 025758/RR/NCRR NIH HHS/United States
- CA055075/CA/NCI NIH HHS/United States
- 1S10RR022586/RR/NCRR NIH HHS/United States
- U01 CA049449/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases